Tom Ling

Tom Ling is an Associate Clinical Operations Asset Lead and Associate Director of Oncology at GSK, where they are currently responsible for the delivery of clinical studies. Tom was recognized as a 2023 Transformational Medicines Award Winner. Their previous experience includes roles as a Global Clinical Development Scientist at GSK, working on significant late-phase assets, and as a Commercial Graduate at Philips Sleep and Respiratory Care, managing customer relations and order processing. Tom completed a First Class degree in Biomedical Sciences at Cardiff University.